174 related articles for article (PubMed ID: 24401108)
21. Current insight into the roles of microRNA in vitiligo.
Yan S; Shi J; Sun D; Lyu L
Mol Biol Rep; 2020 Apr; 47(4):3211-3219. PubMed ID: 32086720
[TBL] [Abstract][Full Text] [Related]
22. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of Serum microRNAs in Autoimmune Pancreatitis.
Hamada S; Masamune A; Kanno A; Shimosegawa T
Digestion; 2015; 91(4):263-71. PubMed ID: 25871699
[TBL] [Abstract][Full Text] [Related]
25. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of MIR409-3p in primary immune thrombocytopenia.
Li H; Zhao H; Xue F; Zhang X; Zhang D; Ge J; Yang Y; Xuan M; Fu R; Yang R
Br J Haematol; 2013 Apr; 161(1):128-35. PubMed ID: 23360331
[TBL] [Abstract][Full Text] [Related]
27. Dissecting genetics of cutaneous miRNA in a mouse model of an autoimmune blistering disease.
Gupta Y; Möller S; Witte M; Belheouane M; Sezin T; Hirose M; Vorobyev A; Niesar F; Bischof J; Ludwig RJ; Zillikens D; Sadik CD; Restle T; Häsler R; Baines JF; Ibrahim SM
BMC Genomics; 2016 Feb; 17():112. PubMed ID: 26879236
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes.
Aguennouz M; Guarneri F; Oteri R; Polito F; Giuffrida R; Cannavò SP
J Dermatol Sci; 2021 Jan; 101(1):22-29. PubMed ID: 33176966
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune melanocyte destruction in vitiligo.
van den Wijngaard R; Wankowicz-Kalinska A; Pals S; Weening J; Das P
Lab Invest; 2001 Aug; 81(8):1061-7. PubMed ID: 11502857
[No Abstract] [Full Text] [Related]
30. Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights.
Abdallah HY; Faisal S; Tawfik NZ; Soliman NH; Kishk RM; Ellawindy A
Mol Diagn Ther; 2023 May; 27(3):405-423. PubMed ID: 37016095
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
[TBL] [Abstract][Full Text] [Related]
33. A miRNA signature of prion induced neurodegeneration.
Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
[TBL] [Abstract][Full Text] [Related]
34. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
[TBL] [Abstract][Full Text] [Related]
36. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases.
Wang B; Yao Q; Xu D; Zhang JA
Int Rev Immunol; 2017 May; 36(3):176-181. PubMed ID: 28471251
[TBL] [Abstract][Full Text] [Related]
38. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
39. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
